ABSTRACT Background: n23 (omega-3) PUFA has been proposed as having health-promoting effects, primarily in relation to ischemic heart disease (IHD). Whether these benefits can be achieved by both a-linolenic acid (ALA, 18:3n23) and n23 long-chain PUFA (LC-PUFA) is debatable. Objective: The objective was to examine the association between ALA intake and risk of IHD in healthy subjects and to see if this was modified by intake of n23 LC-PUFA or linoleic acid (LA, 18:2 n26). Design: This was a prospective cohort study of 3277 healthy Danish women and men free of known IHD. Results: Four hundred seventy-one cases of IHD were observed during a median follow-up period of 23.3 y. Higher intake of ALA was not significantly associated with decreased risk of IHD among women or men. Although the HR of IHD was stepwise decreased with increasing ALA intake in men [0.84 (95% CI: 0.62, 1.14) in the medium compared with the lowest tertile (reference) and 0.83 (95% CI: 0.56, 1.24) in the highest compared with the lowest tertile], this change was far from significant (P-trend: 0.39). No evidence of effect modification by n23 LC-PUFA or LA was observed. High n23 LC-PUFA intake, in comparison with low intake, was inversely associated with risk of IHD; this trend was significant in women (P = 0.04; HR: 0.62; 95% CI: 0.40, 0.97) but not in men (P = 0.15; HR: 0.74; 95% CI: 0.51, 1.06). No associations were observed between intake of LA and risk of IHD. Conclusion: This study suggests that there is no association between ALA intake and risk of IHD, but a high intake of n23 LC-PUFA had a significant cardioprotective effect in women.
INTRODUCTION
Cohort studies and randomized controlled trials generally show that intake of n23 LC-PUFA 4 from fish or fish oil has beneficial effects on IHD, possibly via their triacylglycerollowering, antihypertensive, antithrombotic, antiarrhythmic, and antiinflammatory effects (1) . However, fish and other marine products are limited in many countries (2) , and ALA (18:3n23) from plant oils and nuts (eg, walnuts and flaxseed, soybean, and canola oils) is the predominant source of n23 fatty acids in the typical Western diet. Therefore, whether ALA could be a possible alternative cardioprotective n23 fatty acid is of public health importance.
n23 LC-PUFA, EPA (20:5n23), and DHA (22:6n23) can be synthesized endogenously from ALA. The conversion of ALA and the incorporation of DHA and EPA into tissues (3) (4) (5) (6) (7) (8) is influenced, because of competition, by n26 PUFA, most notably LA (18:2 n26), which accounts for most of the n26 PUFA intake. It has therefore been hypothesized that the effect of n23 fatty acids (ALA and n23 LC-PUFA) may be modified by the intake of LA. Intake of EPA and DHA can also inhibit the activity of D 6 -desaturase and thus the conversion of ALA into n23 LC-PUFA (9) . It is therefore possible that ALA may particularly reduce the risk of IHD among subjects with a low n23 LC-PUFA intake. High intake of n23 LC-PUFA may also blur the effect of ALA because of the former's much higher potency and thus saturation, which seem to occur at intake of fish once a week (1) .
In the present study we used well-validated data from the Glostrup Population Studies to investigate the association between intake of ALA and risk of IHD, specified by the following hypothesis. 1) Intake of ALA is inversely associated with the risk of IHD and 2) the inverse association between ALA and the risk of IHD is modified by the dietary intake of n23 LC-PUFA and/or LA. Previous studies have mainly used foodfrequency questionnaires to assess ALA intake, whereas in the present study we used data from 7-d weighed food records. Furthermore, this study included a heterogeneous group of healthy men and women (eg, not specified by employment) with a wide range of ALA intakes (0.7-2.6 g/d). domly sampled subjects born in 1936 and examined in 1976, 1981, and 1987; 3) the MONICA-I cohort: subjects randomly sampled from births in 1922, 1932, 1942 , and 1952 and examined in 1982; and 4) the MONICA-III cohort: subjects randomly sampled from births in 1932, 1942, 1952 , and 1962 and examined in 1991. The MONICA-I and MONICA-III cohorts were part of the Danish MONICA project, an international study conducted by the World Health Organization (12) . All cohorts met the inclusion criteria: 1) information on dietary intake at baseline determined by 7-d weighed food records and 2) available information on dietary intake of n23 and n26 PUFA. Data from all cohorts were collected by the same institution (Research Centre for Prevention and Health) and usually even by the same trained nurses, dietitians, and technicians. All the subjects in the present study were between 30 and 70 y at their baseline examination visit, which included a self-administered questionnaire on sociodemographic factors, lifestyle, and health as well as a general health examination (11) .
Dietary exposures
All participants were given detailed instructions, verbally and in writing, on how to complete the 7-d weighed food record during an "average" 7-d period (thereby including 1 weekend) with as few preplanned extraordinary social arrangements as possible, and were asked to return the record by mail within 3 wk. The front page contained instructions for correct completion of the record, together with typical household weights of ;20 frequently consumed foods (eg, the weight of an egg, a slice of bread, and so forth). The records included ;100 food items divided into 9 groups: dairy products, bread and cereals, fats, cold cuts and so forth, vegetables, meat (including poultry and fish), drinks, fruit, and miscellaneous. Furthermore, the records had blank pages for foods that did not fit into any of the 9 groups, such as mixed dishes, homemade salads, and cakes (for a more detailed description see 11, 13) . The validity of these 7-d weighed food records has been documented previously, which shows that this method provides a reproducible description of Danish dietary habits with regard to macronutrients (14) . The calculation of daily average intake of nutrients, based on Danish Food Composition Tables, was done with the use of DANKOST 1 and 2 and Micro-Camp computer programs (Danish Catering Center A/S) (15, 16) . Intakes of ALA, n23 LC-PUFA, and LA were expressed in grams per day. Total energy intake was calculated as the sum of energy derived from protein, carbohydrate, and fat.
Nondietary exposures
Leisure-time physical activity was based on how participants placed themselves in the following 4 groups: 1) sedentary leisure-time activities (eg, reading, watching television, going to the cinema); 2) physically active during leisure time (eg, playing table tennis, bowling, walking, and cycling . 4 h/wk; 3) doing sports (eg, running, swimming, playing tennis or badminton) or heavy gardening, building, and so forth .3 h/wk; 4) elite sportsperson (eg, swimming, playing football, long distance running) several times a week. The groups were reclassified so that subjects in groups 3 and 4 were pooled as "active," those in group 2 as "medium active," and those in group 1 as "sedentary." Education was assessed by questions about total years of schooling or highest grade attended, and subjects were classified into 2 groups: 7 y or 8 y. With respect to smoking habits, subjects were classified as never, past, or current smokers of 1-15 g tobacco/d or current smokers of .15 g tobacco/d from information in lifestyle questionnaires. Height and weight were measured when subjects were wearing light clothing and no shoes. Height was measured to the nearest centimeter and weight to the nearest 100 g. BMI (in kg/m 2 ) was calculated as the weight in kilograms divided by the squared height in meters. Blood pressure was measured after 5 min of rest.
IHD event outcomes
Fatal and nonfatal IHD events were defined in accordance with International Classification of Diseases, 8th revision, diagnosis codes 410-414 and International Classification of Diseases, 10th revision, diagnosis codes I20-I25. Cases were identified by record linkage to the National Patient Registry (17) and the Cause of Death Registry (18) . Validation studies have shown high positive predictive values and sensitivities for the myocardial infarction diagnoses registered in the Danish National Hospital Registry (19, 20) .
Statistical analysis
Data analyses were performed with the use of SAS software, version 9.2 (SAS Institute Inc). To calculate HR and 95% CI, we used Cox proportional hazards regression models, with age as the underlying time variable. The observation time for each subject was the period from the date of examination (and thus acquisition of the information on diet) to the date of a IHD event (fatal or nonfatal), death from other causes, emigration, or 31 December 2006, depending on whichever came first. Statistical analyses were carried out separately for men and women (because of different underlying risk of IHD) according to fatty acid intake expressed as tertiles in the case distribution (low, medium, and high intake). Three models were used for investigation of the associations between intake of ALA, n23 LC-PUFA, and LA and risk of IHD. Model 1 included only ALA, n23 LC-PUFA, or LA and cohort identification. Model 2 was the same as model 1, with the addition of known risk factors for IHD: smoking habits, educational attainment, familial history of acute myocardial infarction, systolic blood pressure (mm Hg), indicator variable for alcohol consumption (consumers and nonconsumers), alcohol consumption (in g/d), and other PUFA as appropriate (n23 LC-PUFA and LA in analyses of ALA, ALA and LA in analyses of n23 LC-PUFA, and ALA and n23 LC-PUFA in analyses of LA). Model 3 included the same variables as model 2, with the addition of total energy intake (MJ/d), the recoded leisure-time physical activity variable, and BMI. The results may therefore be interpreted as the effect of the absolute PUFA intake in model 1 and 2 and the energy-adjusted intake (equivalent to percentage of energy) in model 3. We calculated linear trends across increasing intake by assigning the median intake to each category (low, medium, and high) and treating the categories in each model as continuous variables.
We first estimated the association between intakes of ALA, n23 LC-PUFA, and LA and the incidence of morbidity and mortality from IHD. To explore potential effect modification between ALA and n23 LC-PUFA and ALA and LA, we grouped subjects into 9 groups according to high, medium, and low intake of ALA and n23 LC-PUFA or LA (again in tertiles based on case distribution), and added cross-product terms between ALA and n23 LC-PUFA or LA into the fully adjusted model (model 3). Schoenfeld residual plot was used to assess the proportional-hazards assumption, and no violations were detected.
RESULTS
In total, 3427 persons met the inclusion criteria. Those who had been given a previous diagnosis of IHD (n = 38), those who reported that they had diabetes mellitus (n = 79), and those with missing values in the confounding variables (n = 33) were excluded. Thus, the final sample size was 3277 individuals, of whom 1634 were men and 1643 women. During a median follow-up period of 23.3 y we documented 471 cases of IHD. Baseline characteristics of the study population are shown in Table 1 . The median daily intake of ALA was 1.2 g in women and 1.6 g in men.
Among women, no association was observed between intake of ALA and risk of IHD; however, risk of IHD tended to be lower among those with a medium ALA intake compared with those with a low ALA intake ( Table 2) . Also among women, high compared with low n23 LC-PUFA intake was significantly inversely associated with risk of IHD (HR: 0.62; 95% CI: 0.40, 0.97; P for trend: 0.04) after adjustment for potential risk factors for IHD. No association was seen between intake of LA and risk of IHD among women. However, there was a significantly (36%) lower risk of IHD among those with medium LA intake compared with those with low LA intake in statistical model 2, but the significance disappeared in the fully adjusted model.
Among men, there were no significant associations between ALA and n23 LC-PUFA intake and risk of IHD. However, the HR for those with high, compared with low, ALA intake was 0.83 (95% CI: 0.56, 1.24; P for trend: 0.39) and the HR for those with high, compared with low, n23 LC-PUFA intake was 0.74 (95% CI: 0.51, 1.06; P for trend: 0.15) ( Table 2 ). There was no association between intake of LA and risk of IHD among men. To assess possible effect modification by LA and n23 LC-PUFA, we used joint categories of high, medium, and low intake of ALA, LA, and n23 LC-PUFA (in tertiles based on case distribution). The adjusted HRs for IHD according to both ALA and n23 LC-PUFA are shown in Figure 1 . The adjusted HRs for IHD according to ALA and LA are shown in Figure 2 . Evaluation of ALA and n23 LC-PUFA showed that the lowest HRs among men were among those with the highest intake of both fatty acids, compared with those with a low intake of both (HR: 0.61; 95% CI: 0.34, 1.09). We observed no evidence of interaction between ALA and n23 LC-PUFA or ALA and LA (P for interactions .0.05).
No significant associations or trends were seen when 1) the analyses were performed for men and women pooled together, 2) PUFA intakes were included as continuous variables in the analysis, 3) PUFA intakes were included as low and high intake in the analysis, or 4) analyses were also performed to investigate potential effect modification by the LA:ALA ratio (data not shown).
DISCUSSION
In this study no association between ALA intake and risk of IHD was shown, but a high intake of n23 LC-PUFA had a significant cardioprotective effect in women. A cardioprotective effect of ALA has been suggested by a number of observational studies; most studies (21) (22) (23) (24) (25) (26) , but not all (27, 28) , have shown an inverse association between ALA intake and IHD. In 1 Values are presented as HRs; 95% CIs in parentheses. Subjects were grouped in tertiles according to daily intake of ALA (18:3n-3), LA (18:2n26), and n-3 LC-PUFA (low, medium, and high). Cox proportional hazards regression model with age as the underlying time variable was used to calculate HRs and 95% CIs relative to the lowest tertile. Model 1 was the raw cohort association for ALA, n-3 LC-PUFA, or LA, respectively. Model 2 was adjusted as for model 1 but with additional adjustment for smoking, educational attainment, familial history of acute myocardial infarction, systolic blood pressure, alcohol intake, and other PUFAs as appropriate (n-3 LC-PUFA and LA in analyses of ALA, ALA and LA in analyses of n-3 LC-PUFA, and ALA and n-3 LC-PUFA in analyses of LA). Model 3 was adjusted as for model 2 but with the additional inclusion of total energy, leisure-time physical activity, and BMI. ALA, a-linolenic acid; LA, linoleic acid; LC-PUFA, long-chain PUFA. a previous study of ALA intake and risk of IHD and sudden cardiac death among women (21) , it was shown that ALA intake reduced the risk of sudden cardiac death but not the risk of fatal IHD or nonfatal myocardial infarction. In the present study we did not include sudden cardiac death and may thus have missed that type of cardioprotective effect. In theory, it is possible that ALA may particularly reduce the risk of IHD among subjects with a low n23 LC-PUFA intake, as mentioned in the introduction. Mozaffarian et al (25) showed that each 1 g ALA intake/d was associated with a 47% lower risk of IHD among men with little or no n23 LC-PUFA intake (, 1g/d). Contrary to this, we observed no effect modification by n23 LC-PUFA on ALA and the risk of IHD in the present study. The intake of n23 LC-PUFA in most of the subjects in our study was higher, because 0.1 g/d is below the median in the lowest intake tertiles. In addition, with only ;18 cases/group in the interaction analysis among women, we had limited power to detect potential effect modification. However, with slightly more cases in men (35 per group) we observed that those who were in the highest category for both ALA and n23 LC-PUFA had the lowest risk (Figure 1) , which is in accordance with the findings of Albert et al (21) , who showed an additive effect of ALA and n23 LC-PUFA. This indicates that there may have been both an effect modification and an additive effect.
The lack of an association between ALA and risk of IHD may be explained by the competitive actions of LA at the level of the D 6 -desaturase, and a high intake of LA may thus inhibit the effect of ALA on IHD risk. Several human intervention studies (8, (29) (30) (31) (32) suggest that an increase in the intake of LA decreases the amount of ALA that is desaturated and elongated to n23 FIGURE 1. HRs of ischemic heart disease among men (A) and women (B) according to intake of ALA (18:3n-3) and n-3 LC-PUFA in tertiles of intake based on case distribution (low, medium, and high). Cox proportional hazards regression model with age as the underlying time variable was used to calculate HRs and 95% CIs relative to the reference group, which was the group with a low intake of both types of n-3 fatty acids. Among men (n = 1634), there were 152-214 subjects and 34-36 cases in each group; among women (n = 1643), there were 77-251 subjects and 17-19 cases in each group. The models were adjusted for smoking, educational attainment, familial history of acute myocardial infarction, systolic blood pressure, leisure-time physical activity, BMI, and intakes of alcohol, linoleic acid, and total energy. There was no significant evidence for effect modification (P . 0.05 for n-3 LC-PUFA-ALA interaction). ALA, a-linolenic acid; LC-PUFA, long-chain PUFA.
FIGURE 2. HRs of ischemic heart disease among men (A) and women (B) according to intake of ALA (18:3n-3) and LA (18:2n26), expressed as tertiles (low, medium, and high). Cox proportional hazards regression model with age as the time variable was used to calculate HRs and 95% CIs relative to the reference group, which was the group with a low intake of both LA and ALA. Among men (n = 1634), there were 143-233 subjects and 34-36 cases in each group; among women (n = 1643), there were 151-238 subjects and 17-19 cases in each group. The models were adjusted for smoking, educational attainment, familial history of acute myocardial infarction, systolic blood pressure, leisure-time physical activity, BMI, and intakes of alcohol, long-chain n-3 PUFA, and total energy. There was no significant evidence for effect modification (P . 0.05 for LA-ALA interaction). ALA, a-linolenic acid; LA, linoleic acid.
LC-PUFA. However, in our study we observed no evidence that LA intake modified the effect of ALA intake on risk of IHD (Figure 2 ), which is in agreement with the findings of other studies (21, 25, (33) (34) (35) .
The only association we observed in this study was that a high intake of n23 LC-PUFA was significantly related to a lower risk of IHD among women. The effect was not significant in men alone, but the HR estimate for men was, on the other hand, not different from that in women. Therefore, we cannot exclude the possibility that the lack of significance in this estimate may be due to a limitation in power. No clear association between LA and risk of IHD was observed.
In this study we investigated the association between IHD and PUFA intake when expressed as both absolute (models 1 and 2) and relative (model 3) intakes. There were no systematic changes in the HRs, but the CIs became wider in model 3 in the analyses of ALA and LA, which indicates that further adjustment of total energy intake, physical activity, and BMI did not increase the explanatory power. The present study had several other strengths relative to other prospective cohort studies. The dietary assessment was done with the use of a 7-d weighed food record, which does not rely on assumptions about portion sizes and thus is generally believed to give a more precise estimate of intake, relative to a food-frequency questionnaire. Furthermore, the subjects were asked to specify in the records whether they used corn oil, sunflower oil, or soy oil, which ensured that the type of oil was registered correctly. However, fats used for biscuits and ready-made dishes, for example, are often not described accurately and thus are difficult to assess (36) . A limitation of the weighed food record is the limited number of days, which is especially important with regard to the more rarely eaten foods (ie, fish). Thus, there is a risk of over-or underestimation of fish intake in the individual participants.
Errors in the assessment of PUFA intake may have weakened the ability to detect potential associations. Jørgensen et al (14) assessed the validity of the 7-d weighed food records used in the Glostrup Population Studies and concluded that use of these records was a reliable method for the description of dietary habits with regard to macronutrient intake, but PUFA intake was not included in the validation. However, we analyzed PUFA intake at the group level (in tertiles) instead of continuous variables, and validity is usually better at the group level. Høidrup et al (13) concluded that the 7-d weighed food records in the Glostrup Population Studies resulted in an age-and BMI-dependent underestimation of energy intake. This was supported by Heitmann and Lissner (37) , who concluded that obese people from the MONICA studies tended to specifically underreport fatty foods and foods rich in carbohydrates. If the obese subjects in our study selectively underreported their fat intake, this may have produced differential misclassification bias. Because obesity is a predictor of IHD, the misclassification of dietary fat may have been different for those who developed IHD and for those who did not. However, because the proportion of obese subjects was relatively low, differential misclassification may not have influenced the results. BMI was also included as a potential confounder and is therefore included as an explanatory variable in the models. Only baseline information about dietary habits was available. The lack of repeated assessment of dietary intakes excludes the possibility of analytic approaches to reduce measurement error. Confounding from other nonassessed IHD risk factors is always a problem in cohort studies. For example, in the present study we did not adjust for trans fatty acids, and this may be a problem because other studies (27, 38) have shown strong associations between intakes of ALA and trans fatty acids. Selection bias is also not likely to have affected the study, because loss to followup was negligible (0.58%). The long follow-up period in the present study provided more cases and therefore more statistical power for the main analyses of ALA intake and risk of IHD, but we may have had inadequate power to detect potential effect modification by n23 LC-PUFA and LA, especially among women.
The estimated median daily intake of ALA in the present study was 1.2 g/d and 1.6 g/d among women and men, respectively. In comparison, the median daily intake was 1.1 g/d in the Health Professionals Study (39) and in the Nurses' Health Study (33) , and the median intake for men and women in the EPIC (European Investigation into Cancer and Nutrition)-Norfolk cohort was 1.2 g/d and 0.99 g/d, respectively (40) . The estimated minimum requirement of ALA is 0.5% of energy (;1.2 g/d) in adults (41) . Thus, about one-half of our study population was under the minimum requirement, whereas others had intakes well above 2 g/d. We therefore had a very wide range of intake, which was higher than in some of the previous large cohort studies in this field [eg, 0.79-1.47 g/d in the Health Professionals Follow-Up Study (25) ]. Heterogeneity in the intake of interest is essential for the ability to detect potential associations with health. On the basis of our results we therefore conclude that higher intake of n23 LC-PUFA, but not ALA (and LA), reduced the risk of IHD among a representative subgroup of Danish women and men. Further larger studies are warranted to examine potential effect modification by different PUFA.
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